Clinicopathologic Characteristics of Mesonephric Adenocarcinomas and Mesonephric-like Adenocarcinomas in the Gynecologic Tract
Authors:
Top Cited Papers
- 1 April 2021
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 45 (4) , 498-506
Abstract
Mesonephric adenocarcinoma (MA) and mesonephric-like adenocarcinoma (MLA) are uncommon neoplasms of the gynecologic tract that have until recently been poorly understood. Although their morphologic, immunohistochemical, and molecular profiles have been recently defined, little is known about their clinical behavior. Small studies have demonstrated inconsistent findings and no large studies have examined the clinical behavior of these adenocarcinomas. In this multi-institutional study, representing the largest and most stringently defined cohort of cases to date, we examined the clinicopathologic features of 99 MAs and MLAs (30 MAs of the uterine cervix, 44 MLAs of the endometrium, and 25 MLAs of the ovary). Only tumors with characteristic mesonephric morphology and either immunohistochemical or molecular support were included. Our results demonstrate that the majority of mesonephric neoplasms presented at an advanced stage (II to IV) (15/25 [60%] MA of the cervix, 25/43 [58%] MLA of the endometrium, and 7/18 [39%] MLA of the ovary). The majority (46/89 [52%] overall, 12/24 [50%] MA of the cervix, 24/41 [59%] MLA of the endometrium, and 10/24 [42%] MLA of the ovary) developed recurrences, most commonly distant (9/12 [75%] MA of the cervix, 22/24 [92%] MLA of the endometrium, and 5/9 [56%] MLA of the ovary). The 5-year disease-specific survival was 74% (n=26) for MA of cervix, 72% (n=43) for MLA of endometrium, and 71% (n=23) for MLA of ovary. Our results confirm that mesonephric neoplasms are a clinically aggressive group of gynecologic carcinomas that typically present at an advanced stage, with a predilection for pulmonary recurrence.Keywords
This publication has 39 references indexed in Scilit:
- Napsin A is a useful marker for metastatic adenocarcinomas of pulmonary originHistopathology, 2014
- Comparison of clinical outcomes of patients with clear cell and endometrioid ovarian cancer associated with endometriosis to papillary serous carcinoma of the ovaryGynecologic Oncology, 2014
- Thyroid transcription factor‐1 (TTF‐1) immunoreactivity is an adverse prognostic factor in endometrioid adenocarcinoma of the uterine corpusHistopathology, 2014
- Mesonephric adenocarcinoma of the uterine cervix and literature reviewBMJ Case Reports, 2012
- Mesonephric Adenocarcinomas of the Uterine Cervix and CorpusAmerican Journal of Surgical Pathology, 2012
- Five commonly used markers (p53, TTF1, CK7, CK20, and CK34βE12) are of no use in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray extension studyArchives of Gynecology and Obstetrics, 2009
- Thyroid Transcription Factor-1 Expression in Endometrial and Endocervical AdenocarcinomasAmerican Journal of Surgical Pathology, 2007
- Gastric Morphology and Immunophenotype Predict Poor Outcome in Mucinous Adenocarcinoma of the Uterine CervixAmerican Journal of Surgical Pathology, 2007
- A Report of Eight Cases, Including Four with a Malignant Spindle Cell ComponentAmerican Journal of Surgical Pathology, 1995
- Mesonephric Remnants, Hyperplasia, and Neoplasia in the Uterine CervixAmerican Journal of Surgical Pathology, 1990